These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10413360)

  • 1. Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children.
    Peters VB; Mayer L; Sperber KE
    Viral Immunol; 1999; 12(2):139-48. PubMed ID: 10413360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vitro T-cell and B-cell function with responses to childhood vaccines in children with human immunodeficiency virus infection.
    Peters VB; Mayer LF; Sperber KE
    Viral Immunol; 1997; 10(4):197-206. PubMed ID: 9473150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.
    Simani OE; Izu A; Violari A; Cotton MF; van Niekerk N; Adrian PV; Madhi SA
    AIDS; 2014 Feb; 28(4):531-41. PubMed ID: 24468996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of three antiretroviral regimens in HIV-1-infected children.
    Luzuriaga K; McManus M; Mofenson L; Britto P; Graham B; Sullivan JL;
    N Engl J Med; 2004 Jun; 350(24):2471-80. PubMed ID: 15190139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
    Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
    N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART).
    Ching N; Deville JG; Nielsen KA; Ank B; Wei LS; Sim MS; Wolinsky SM; Bryson YJ
    Eur J Pediatr; 2007 Jan; 166(1):51-6. PubMed ID: 16868780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
    Ghaffari G; Passalacqua DJ; Caicedo JL; Goodenow MM; Sleasman JW
    Pediatrics; 2004 Nov; 114(5):e604-11. PubMed ID: 15492356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
    Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
    Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
    Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
    N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
    Ratto-Kim S; Garner RP; Kim JH; Jagodzinski LL; Michael NL; Paris R; Redfield RR; Birx DL
    J Infect Dis; 2004 Jun; 189(11):1988-95. PubMed ID: 15143464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life.
    Borkowsky W; Rigaud M; Krasinski K; Moore T; Lawrence R; Pollack H
    J Pediatr; 1992 Mar; 120(3):371-5. PubMed ID: 1538282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.
    Kroon FP; van Dissel JT; Labadie J; van Loon AM; van Furth R
    Clin Infect Dis; 1995 Nov; 21(5):1197-203. PubMed ID: 8589143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.